Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | SSTR5 | P35346 | 2/20 | 0.43 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.43 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.43 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.43 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GJB2 | P29033 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13129833 | 1.00 | LGALS8 (0.45) | LGALS8SSTR5SSTR1SSTR2SSTR4 | |
| SCHEMBL8328774 | 0.91 | SSTR5 (0.46) | LGALS8SSTR5SSTR1SSTR2SSTR4 | |
| SCHEMBL19620385 | 0.91 | SSTR5 (0.46) | LGALS8SSTR5SSTR1SSTR2SSTR4 | |
| SCHEMBL19226930 | 0.91 | SSTR5 (0.46) | LGALS8SSTR5SSTR1SSTR2SSTR4 | |
| SCHEMBL19620495 | 0.91 | SSTR5 (0.46) | LGALS8SSTR5SSTR1SSTR2SSTR4 | |
| SCHEMBL9617274 | 0.91 | PDPK1 (0.42) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL9503678 | 0.89 | SSTR5 (0.41) | LGALS8SSTR5SSTR1SSTR2SSTR4 | |
| SCHEMBL7892058 | 0.89 | SSTR5 (0.41) | LGALS8SSTR5SSTR1SSTR2SSTR4 | |
| SCHEMBL8332110 | 0.89 | SSTR5 (0.46) | LGALS8SSTR5SSTR1SSTR2SSTR4 | |
| SCHEMBL22212491 | 0.87 | LGALS8 (0.49) | LGALS8SSTR5SSTR1SSTR2SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119586700-A | Pet food for improving excreta peculiar smell and preparation method thereof | 江苏省农业科学院 | 2025-03-11 | — | — | CN | disclosed |
| US-10087242-B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | INSTITUT PASTEUR (FR) | 2018-10-02 | — | — | US | disclosed |
| EP-2164521-B1 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3A AND X | PASTEUR INSTITUT (FR) | 2018-09-12 | — | — | EP | disclosed |
| US-20150050282-A1 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3a AND X | INSTITUT PASTEUR (FR) | 2015-02-19 | — | — | US | disclosed |
| US-8815239-B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | INSTITUT PASTEUR (FR) | 2014-08-26 | — | — | US | disclosed |
| US-20100239584-A1 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3A AND X | INSTITUT PASTEUR (FR) | 2010-09-23 | — | — | US | disclosed |
| EP-2164521-A2 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST<I>SHIGELLA FLEXNERI</I>SEROTYPE 3A AND X | Institut Pasteur (FR) | 2010-03-24 | — | — | EP | disclosed |
| WO-2008155487-A2 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3A AND X | INSTITUT PASTEUR (FR) | 2008-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10087242-B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | ST3GAL3, SI, STT3A | LGALS8 130/4885SSTR5 684/4885SSTR1 1053/4885 |
| US-20100239584-A1 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3A AND X | ST3GAL3, SI, STT3A | LGALS8 130/4885SSTR5 684/4885SSTR1 1053/4885 |
| US-20150050282-A1 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3a AND X | ST3GAL3, SI, STT3A | LGALS8 130/4885SSTR5 684/4885SSTR1 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.